---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-277952"
form_type: "8-K"
ticker: "TMDX"
cik: "0001756262"
company_name: "TransMedics Group, Inc."
filed_at: "2022-11-04T23:59:59+00:00"
generated_at: "2026-06-22T07:11:04.018666+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# TransMedics amends bylaws to incorporate SEC universal proxy rule requirements

## Summary
- Board approved Second Amended and Restated Bylaws, effective November 2, 2022.
- Amends director nomination procedures to require compliance with SEC Rule 14a-19 (universal proxy).
- Shareholders must disclose proxy solicitation intent and notify company if they fail to comply with Rule.
- No successor, substitute, or replacement nominees allowed after the nomination deadline.

## SEC filing metadata
- accession: 0001193125-22-277952
- form_type: 8-K
- ticker: TMDX
- cik: 0001756262
- company_name: TransMedics Group, Inc.
- filed_at: 2022-11-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1756262/000119312522277952/0001193125-22-277952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1756262/000119312522277952/d401238d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-277952
- JSON: https://secwatch.observer/filing/0001193125-22-277952.json
- Plain text: https://secwatch.observer/filing/0001193125-22-277952.txt

## Key facts
- Governance Changes
  TransMedics Group, Inc.: Amended Bylaws to update procedural requirements for director nominations reflecting SEC's universal proxy rules and other administrative changes (effective 2022-11-02).
  - Change: bylaw amendment
  - Effective: 2022-11-02
  source text: On November 2, 2022, the Board of Directors (the “Board”) of TransMedics Group, Inc. (the “Company”) approved the Company’s Second Amended and Restated Bylaws (as so amended and restated, the “Amended Bylaws”), effective as of such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1756262/000119312522277952/0001193125-22-277952-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.